Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Bionovate Technologies Corp. | biio_8k.htm |
Exhibit 16.1
April 5, 2018
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Ladies and Gentlemen:
We have read Item 4.01 of the Form 8-K dated April 5, 2018, of Bionovate Technologies Corp. and are in agreement with the statements pertaining to our firm contained in section a) We have no basis to agree or disagree with other statements of the registrant contained therein.
Sincerely,
MNP LLP